SAN DIEGO, Jan. 6, 2014 /PRNewswire/ --Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company providing innovative
diagnostic testing and genetic analysis solutions, today announced
the Company's participation at the J.P. Morgan 32nd Annual
Healthcare Conference at the Westin St. Francis Hotel in
San Francisco, California on
January 13-16, 2014.
(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)
Harry Hixson, Chairman and CEO,
William Welch, President and COO,
and Paul V. Maier, Chief Financial
Officer, will present on Thursday, January
16, 2014 beginning at 2:00 p.m.
PT, and provide an overview of and update on the Company.
The presentation is expected to last approximately 30 minutes and
will be an audio webcast live through the "Invest" section of the
Sequenom Web site at www.sequenom.com. An audio replay will be
available for 90 days following the initial presentation.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life
sciences company committed to improving healthcare through
revolutionary genomic and genetic analysis solutions. Sequenom
develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular
diagnostic markets. The company was founded in 1994 and is
headquartered in San Diego,
California. Sequenom maintains a Web site at
http://www.sequenom.com to which Sequenom regularly posts copies of
its press releases as well as additional information about
Sequenom. Interested persons can subscribe on the Sequenom Web site
to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other
information to the Web site.
SOURCE Sequenom, Inc.